Ketamine therapy, particularly in the form of intravenous (IV) infusions, has become a go-to treatment for severe depression in New York, yet the insurance wall remains a significant barrier to access. Navigating the financial divide between FDA-approved (Food and Drug Administration) nasal sprays and off-label IV drips requires a clear roadmap to ensure you do not face unexpected out-of-pocket costs. Here we offer guidance for NY patients who are considering their treatment options and wondering whether ketamine therapy is covered by insurance, especially following little to no success with traditional antidepressants.
By submitting this form you agree to be contacted via phone/text/email.
Understanding whether you qualify for insurance-backed ketamine therapy starts with your medical history and specific diagnosis. Most insurance carriers in New York, including UnitedHealthcare and Cigna, strictly adhere to the definition of treatment-resistant depression. This requires documented evidence that you have tried at least two different classes of antidepressants without significant clinical improvement.
Your PHQ-9 score, a standardized depression screening tool, is often the most critical document in your medical file. Insurers use these scores to track the severity of your symptoms and determine the medical necessity of advanced interventions like ketamine. Keeping accurate records of your previous medications and their lack of efficacy is essential for a successful prior authorization.
A major shift that began in 2025 is the acceptance of Spravato (esketamine) as a monotherapy. Previously, many insurers required patients to stay on a daily oral antidepressant while receiving ketamine treatments. Now, Spravato is being recognized as a standalone treatment for TRD.
For patients seeking the highest level of insurance support, Spravato remains the most reliable option. Major New York carriers such as Empire Blue Cross Blue Shield (Anthem) have established clear pathways for covering this FDA-approved nasal spray. Because it is administered in a REMS-certified (Risk Evaluation and Mitigation Strategies) facility, insurance companies view Spravato as a controlled, medical-grade treatment rather than an elective service.
NYRx Medicaid also provides coverage for Spravato to eligible New Yorkers with prior authorization. This is particularly important for patients in NY who rely on public health benefits for their mental healthcare. The financial burden is further reduced by the Spravato withMe Program, which is a manufacturer savings initiative. For patients with private insurance, this program can lower the drug’s copay to as little as $10 per session.
Unlike Spravato, IV ketamine infusions are currently classified as off-label for the treatment of psychiatric disorders. This means that while doctors can legally prescribe them, insurance companies like Aetna often label the drug itself as experimental or investigational. Consequently, getting a direct “yes” for IV infusion coverage is significantly more difficult than for nasal sprays.
However, many patients successfully lower their costs by using a “superbill” strategy. A superbill is a detailed receipt that includes specific medical coding for your visit. While the insurer may deny the cost of the ketamine itself, they may reimburse you for the office visit or the medical administration of the IV.
Patients should look for two specific CPT (Current Procedural Terminology) codes on their documentation: 99214 and 96365. Code 99214 covers the high-level evaluation and management performed by a physician. Code 96365 is the standard code for intravenous infusion for the first hour of administration. By submitting the codes, you may receive reimbursement for a portion of the service fees.
Even if you meet the clinical criteria for ketamine, certain administrative errors can lead to claim denial. The first major red flag is receiving treatment at a facility that is not REMS-certified. Insurance providers will only reimburse for Spravato if the clinic follows strict safety protocols mandated by the FDA.
Incomplete medical history documentation is another common reason for denial. If your records do not clearly list the names, dosages, and dates of the two antidepressants you failed, the insurer will likely reject the request for TRD status.
Finally, insurance companies will almost never cover at-home compounded ketamine. These products are often seen as high-risk and lack the supervised environment required for safety.
The financial landscape of ketamine therapy in 2026 is complex but navigable with the right professional guidance. While IV infusions remain a “maybe” for direct insurance coverage, the “yes” pathway for Spravato and the strategic use of superbills offer viable options for most New York patients.
Alternatively, if you’re ready to shoulder the cost of mental health relief through intravenous treatment, contact Ketamine Wellness NY today. We have clinics in Jackson Heights and Great Neck Plaza, with an expert team delivering ketamine IV therapy under strict medical supervision. We offer a package of six IV drips for $3,150, which lowers the per-session cost ($650; introductory price of $550 for new patients) compared to individual sessions.
“Brent is the best. I’m doing the six-drip ketamine treatment plan. He is informative and makes me feel relaxed. I’m starting to see improvements and having less anxiety attacks.” Ketamine Wellness NY patient
Spravato is FDA-approved and highly covered by most New York insurers. IV ketamine is used off-label, meaning insurance rarely covers the drug itself but may reimburse for the administration and doctor’s visit via a superbill. New York Medicaid, for instance, covers Spravato for patients who meet the clinical criteria for treatment-resistant depression. It does not currently cover off-label ketamine infusions.
You must provide documented evidence from your medical records showing that you have tried at least two different antidepressant medications without success. These antidepressants must have been taken at a therapeutic dose. So, if you tried an SSRI (selective serotonin reuptake inhibitor) and an SNRI (serotonin and norepinephrine reuptake inhibitor) without success, you likely meet the foundational requirement. The documentation will be used in filing a prior authorization with your insurer.
As of this writing, off-label ketamine IV therapy is not yet covered by insurance. In certain instances, you may be reimbursed for the doctor’s visit (not the drip itself) through what is called a superbill.
Yes, you can request a superbill to submit to your insurer. While coverage is not guaranteed, there are patients who receive partial reimbursement for the physician’s evaluation and the infusion administration.
As of 2025, insurance policies have begun reflecting Spravato’s updated status as a monotherapy. This means many patients can now get coverage for the nasal spray even if they are not currently taking a daily oral medication.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on our website are based on information drawn from medical research, societies, and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Ketamine therapy, particularly in the form of intravenous (IV) infusions, has become a go-to treatment
Living in New York City often means paying a premium for everything, from rent to
For many individuals living with obsessive-compulsive disorder (OCD), the mind feels like a transmission with
Ketamine therapy is gaining popularity for its ability to alleviate severe depressive symptoms in hours
Finding affordable mental healthcare in New York can feel like navigating a maze, especially when
For many, therapy offers a vital path to healing and self-discovery. However, after years of
New York City’s relentless pulse can at times push its residents to the brink. The
Navigating the bustling rhythm of New York City can make even routine tasks feel like
Embarking on a journey with ketamine therapy can be a significant step toward mental wellness,
Treatment-resistant depression (TRD) can leave many exhausted and without hope after conventional treatments fail. When
Experiencing severe anxiety or post-traumatic stress disorder (PTSD) can feel like an unending struggle, especially
Considering ketamine therapy in New York City can feel overwhelming, with a growing number of
Living with chronic pain can be an isolating and debilitating experience, often leading to a
The growing hope for ketamine therapy in treating conditions like depression and chronic pain is
Imagine a snow-covered hill where sledders have repeatedly carved deep, unchanging ruts, making it nearly
If you’ve experienced the profound frustration, exhaustion, and despair of depression that simply won’t respond
Anxiety impacts millions, leading many to seek relief through medications like benzodiazepines. While effective for
Selective serotonin reuptake inhibitors (SSRIs) have long been a known antidepressant, while ketamine has emerged
Experiencing physical shaking, trembling, tightness, or nausea due to anxiety can be distressing and often
It can be largely disheartening when you’ve followed all the advice, taken your antidepressant as
Thank you for choosing Wellness Clinic. Our specialist care team will contact you within the next 12 hours to confirm your appointment and answer any questions youmay have.
our team will review your message and contact your shortly. we look forward to supporting your wellness journey
Check your phone or email to receive your unique coupon code. You’ll need it when booking your first appointment.
